Home › Interstitial Lung Diseases › Oregon
Interstitial Lung Diseases clinical trials in Oregon
9 studies for Interstitial Lung Diseases are looking for participants at sites in Oregon.
Cities in Oregon
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA003, Bend
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07179380A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
- Clinical Research Site, Bend
RecruitingPhase 3
Ages 18 to 85 · All sexes · Updated Sep 11, 2026 · NCT07816185A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Summit Health, Bend
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Sep 2, 2026 · NCT07285655DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Summit Health, Bend
- Legacy Research Institute, Portland
- Oregon Health & Science University, Portland
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 26, 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Oregon Health & Science University (OHSU), Portland
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- USA003, Bend
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT07234032Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Oregon Clinic, Portland
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
- Bend Memorial Clinic, Bend
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Aug 10, 2026 · NCT07175038An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH
- Summit Health, Bend
RecruitingObservational study
Ages 18 to 80 · All sexes · Updated Jun 26, 2026 · NCT06129240From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.